Albuminuria in Saudi Patients with Type 2 Diabetes and Hypertension

Khalid S. Aljabri, MD, FRCPC, FACP^1*, Samia A. Bokhari, MD, SBEM¹, Muneera A. Alshareef, MD, SBIM¹, Patan M. Khan, MD, MRCP¹, Hesham M. AbuElsaoud, MD¹, Mohammad M. Jalal, MD¹, Rania F. Safwat, MD¹, Rehab El Boraie, MD¹, Nawaf K. Aljabri, MLT², Bandari K. Aljabri, MS³ & Arwa Y. Alsuraihi, MS³

¹Department of Endocrinology, King Fahad Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia
²Department of Laboratory, Northern Armed Forces Hospital, Hafr Al-Batin, Kingdom of Saudi Arabia
³College of Medicine, Um Al Qura University, Makkah, Kingdom of Saudi Arabia

Dr. Khalid S. Aljabri, MD, FRCPC, FACP, Department of Endocrinology, King Fahad Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia.

Keywords: Type 2 Diabetes; Hypertension; Albuminuria

Abstract

Background and Objective
Albuminuria is a risk factor for cardiovascular disease, and excess urinary albumin is related to increased all-cause mortality. Patients with type 2 diabetes (T2DM) are almost twice as likely to have hypertension (HTN) as the nondiabetic population. There have been few reported studies in national, regional and Asian populations on the prevalence of microalbuminuria in this high risk population. Therefore, we retrospectively evaluated the prevalence of albuminuria in Saudi patients with T2DM and HTN.
Methods
For the present retrospective study, we analyzed 2315 participants whom are between the age 20 to 98 years. All patients were from the population of the diabetic centre and Primary health centre at King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia. All data were collected on the basis of a review of electronic medical data.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).